Fastenal EVP granted 17,560 stock options

Fastenal Company executive James C. Jansen, EVP-Manufacturing, reported a new stock option grant.

Rhea-AI Filing Summary

Fastenal Company executive James C. Jansen, EVP-Manufacturing, reported a new stock option grant. On 01/02/2026, he received an employee stock option giving the right to buy 17,560 shares of Fastenal common stock at an exercise price of $41 per share. The option was granted at no cost to him and is held directly.

The option will vest over four years, with 25% of the grant becoming exercisable on each anniversary of the grant date, until fully vested. The option expires on 12/31/2035 if not exercised. Following this grant, Jansen beneficially owns 17,560 derivative securities in the form of these stock options.

Insider Trade Summary

Grant/Award: 17,560 shares

Grant/Award 1 txn

Insider Jansen James C

Role EVP-Manufacturing

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (Right to Buy)	17,560	$0.00	$0.00

Holdings After Transaction: Employee Stock Option (Right to Buy) — 17,560 contracts (Direct)

Footnotes (1)

1. F1. The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FAST report for James C. Jansen on this Form 4?

The filing reports that EVP-Manufacturing James C. Jansen received an employee stock option grant for 17,560 Fastenal common shares on 01/02/2026.

How many Fastenal stock options were granted to James C. Jansen?

James C. Jansen was granted an employee stock option covering 17,560 shares of Fastenal common stock.

What is the exercise price of James C. Jansen’s Fastenal stock options?

The employee stock option granted to James C. Jansen has an exercise price of $41 per share.

How do the Fastenal stock options granted to James C. Jansen vest?

The option vests over four years, with 25% of the grant vesting and becoming exercisable each year following the 01/02/2026 grant date.

When do James C. Jansen’s Fastenal stock options expire?

The employee stock option granted to James C. Jansen expires on 12/31/2035 if not exercised.

Does James C. Jansen hold the Fastenal stock options directly or indirectly?

The Form 4 indicates that the 17,560 employee stock options are held directly by James C. Jansen.

How many derivative securities does James C. Jansen beneficially own after this transaction?

After this grant, James C. Jansen beneficially owns 17,560 derivative securities in the form of employee stock options.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/06/2026 - 12:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jansen James C

(Last) (First) (Middle)

2001 THEURER BLVD.

(Street)

WINONA MN 55987

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
FASTENAL CO [ FAST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP-Manufacturing

3. Date of Earliest Transaction (Month/Day/Year)
01/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$41	01/02/2026		A		17,560		(1)	12/31/2035	Common Stock	17,560	$0	17,560	D

Explanation of Responses:

1. The option will fully vest and become exercisable over a period of four years, with 25% vesting and becoming exercisable each year following the grant date.

Remarks:

	/s/ John J. Milek, Attorney-in-Fact	01/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.